LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

Search

Bio-Rad Laboratories Inc

Closed

SectorHealthcare

232.13 0.65

Overview

Share price change

24h

Current

Min

222.05

Max

232.44

Key metrics

By Trading Economics

Income

780M

64M

Sales

-82M

585M

EPS

2.54

Profit margin

10.933

Employees

7,700

EBITDA

75M

134M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+36.5% upside

Dividends

By Dow Jones

Next Earnings

31 lip 2025

Market Stats

By TradingEconomics

Market Cap

-344M

6.2B

Previous open

231.48

Previous close

232.13

News Sentiment

By Acuity

50%

50%

172 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 cze 2025, 20:41 UTC

Earnings

Adobe Raises Outlook After 2Q Sales Beat

12 cze 2025, 23:50 UTC

Earnings

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 cze 2025, 23:50 UTC

Earnings

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 cze 2025, 23:50 UTC

Earnings

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 cze 2025, 23:48 UTC

Market Talk

Gold Steady Amid Geopolitical Risks -- Market Talk

12 cze 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 cze 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 cze 2025, 21:26 UTC

Earnings

Friedman Industries 4Q Sales $129.2M >FRD

12 cze 2025, 21:25 UTC

Earnings

Friedman Industries 4Q EPS 76c >FRD

12 cze 2025, 21:11 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 cze 2025, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 cze 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 cze 2025, 20:31 UTC

Earnings

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 cze 2025, 20:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 cze 2025, 20:15 UTC

Earnings

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 cze 2025, 20:15 UTC

Earnings

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 cze 2025, 20:14 UTC

Earnings

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 cze 2025, 20:07 UTC

Earnings

Adobe Raises FY25 Rev and EPS Targets

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Net $1.69B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q EPS $3.94 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Rev $5.87B >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 cze 2025, 20:05 UTC

Earnings

Adobe 2Q Adj EPS $5.06 >ADBE

Peer Comparison

Price change

Bio-Rad Laboratories Inc Forecast

Price Target

By TipRanks

36.5% upside

12 Months Forecast

Average 314.2 USD  36.5%

High 381 USD

Low 245 USD

Based on 5 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

3

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

229.835 / 235.8095Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

172 / 380 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.